Framework Agreement between Andritz AG and Technopromexport to Jointly Develop and Implement Hydropower Projects in Commonwealth of Independent States (CIS)

Reportstack has announced a new market report on Framework Agreement between Andritz AG and Technopromexport to Jointly Develop and Implement Hydropower Projects in Commonwealth of Independent States (CIS). JSC Technopromexport (TPE) and Andritz AG have agreed to enter into a partnership for the construction of hydropower plants in Commonwealth of Independent States (CIS). TPE is engaged in the construction of power projects and is a subsidary of Rostec State Corporation, while Andritz AG is a supplier of electromechanical systems and a provider of services for hydropower plants. The agreement will be effective for one year from the date of its signature and may be tacitly prolonged with the consent of both parties.

Under the terms of the agreement, TPE will act as general contractor, and will manage engineering and construction work as well as installing and commissioning equipment. Andritz AG will design, produce and supply equipment.

Scope

- The deal report analysis reason behind the partnership and explains the key drivers of this deal.
- The report covers the brief overview of the companies involved in the transaction and few comparable deals.

Reasons to buy

- This report provides insight about the partnership between Andritz AG and Technopromexport (TPE).
- The deal analyses the rationale and drivers behind the partnership.

To view the table of contents and know more details please visit Framework Agreement between Andritz AG and Technopromexport to Jointly Develop and Implement Hydropower Projects in Commonwealth of Independent States (CIS) report

PharmaPoint: Meningococcal Vaccines - Current and Future Players

Reportstack has announced a new market report on PharmaPoint: Meningococcal Vaccines - Current and Future Players which  is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Meningococcal Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Meningococcal Vaccines market. The report provides insight into the competitive Meningococcal Vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by a team of industry experts.

Scope

- Investigation of current and future market competition for Meningococcal Vaccines
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the Meningococcal Vaccines sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving the Meningococcal Vaccines Market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Meningococcal Vaccines market landscape? Identify, understand and capitalize


The Companies Mentioned in this report are Sanofi Novartis GlaxoSmithKline Baxter Nuron Biotech Pfizer.

To view the table of contents and know more details please visit PharmaPoint: Meningococcal Vaccines - Current and Future Players report.

John Wood Group and Siemens to Form Joint Venture to Enhance their Global Turbine Services Market Position

Reportstack has announced a new market report on John Wood Group and Siemens to Form Joint Venture to Enhance their Global Turbine Services Market Position . On October 9, 2013, John Wood Group PLC (Wood Group), an energy services company, and Siemens AG (Siemens), an electronics and electrical engineering company, announced their intention to enter into a Joint Venture (JV) to provide services for gas turbines, steam turbines and generators across a range of Original Equipment Manufacturer (OEM) equipment for sectors including power generation, oil and gas, and industries. The JV will consist of the maintenance and power solutions businesses of Wood Group Gas Turbine Services (WGGTS) and Siemens’ TurboCare business unit, which provides aftermarket design, repair and manufacturing services for gas turbines, steam turbines and generators. The JV will enable Wood Group and Siemens to enhance their position in the growing global gas-turbine market.

Scope

- The information related to the Joint Venture between John Wood Group and Siemens
- Key drivers of the deal
- Rationale of the deal
- A brief on John Wood Group, Wood Group GTS, Siemens, TurboCare Inc.

Reasons to buy

- Understand the reasons for the joint venture
- Understand the response from the markets
- Understand the impact of the deal on John Wood Group and Siemens

To view the table of contents and know more details please visit John Wood Group and Siemens to Form Joint Venture to Enhance their Global Turbine Services Market Position  report

Distributed Generation and Smarter Transmission Tweaking the European Electricity Business Model

Reportstack has announced a new market report on Distributed Generation and Smarter Transmission Tweaking the European Electricity Business Model. Since 2006, the European power sector has had to change according to the new legislation and targets set by the European Union (EU) in the areas of environmental sustainability, security of supply, and competitiveness, the so-called “three pillars” of European Union energy policy. These changes have taken place due to rising demand for electricity, depletion of fossil fuels and increased Carbon Dioxide (CO2) emissions (JRC, 2008). The European nations are now looking for alternative ways to meet the increasing demand for electricity. The integration of Renewable Energy Sources (RES) into the grid to decrease emissions and conserve fossil fuels has been the major aim of the European governments. A number of plans and policies such as the EU Directive 2001/77/EC, Directive 2009/28/EC, and the European Strategic Energy Technology Plan (SET-Plan) have been put in place to support the growth of RES. A number of Distributed Generation (DG) activities are occurring across Europe, which may lead to centralized generation and transmission. The integration of RES into the power grid leads to challenges in terms of grid connection, such as harmonization in grid connection requirements, insufficient curtailment rules, compensation issues, future increases in curtailment, and lack of consideration for RES in national transmission system development plans.

Scope

- Role of distributed generation and smart grid technologies in the present business context
- Major plans and policies driving the growth of renewable energy sources in Europe
- Selected list of distributed generation and smart grid project activities across Europe
- Barriers associated with grid integration of distributed generation in Europe

Reasons to buy

- Gain insight into the benefits involved with decentralized power systems.
- Comprehend the restraints involved with grid integration of distributed generation.
- Identify the key activities and programs driving distributed generation in Europe.
- Gain insight into how distributed generation and smarter transmission is transforming the European electricity business model.

To view the table of contents and know more details please visit Distributed Generation and Smarter Transmission Tweaking the European Electricity Business Model report.

China TV Drama Industry Report,2013-2016

Reportstack has announced a new market research publication on China TV Drama Industry Report,2013-2016. In recent years, a series of favorable policies issued by the Chinese government in finance, intellectual property protection and culture industries stimulate the rapid expansion of Chinese TV drama market.

In 2012, 612 TV dramas were launched in China, rising by 50 ones year on year; 19,659 episodes were issued, representing a year-on-year increase of 2,941 ones. Meanwhile, 506 TV dramas made in China (accounting for 82.68%) were published, up 37 ones year on year; 17,703 episodes were released, with a year-on-year growth of 18.48%. The length of each TV drama made in China ascended from 27.58 episodes in 2006 to 34.99 episodes in 2012 averagely.

In 2012, the transaction value of TV dramas made in China jumped by 44.74% year on year to RMB11 billion, of which RMB8 billion sourced from broadcast copyright trading and RMB3 billion from network copyright trading. In 2011-2012, the transaction value increased significantly mainly because of the growing number of higher-priced classic dramas.

By H1 2013, there had been seven Chinese listed companies engaged in television production and distribution. In 2008-2012, their TV drama revenue grew at over 30%; by the CAGR of TV drama revenue, New Culture (88.67%), Enlight Media (81.63%) and Huace (61.26%) ranked the top three.

In 2012, five ones of these seven listed companies gained the gross margin of 40% or more. In point of gross margin, the top three companies were Huayi Brothers (56.02%), Huace (55.74%) and Hualu Baina (44.90%).

In the future, with the increase of Chinese TV drama platforms, the demand for high-quality dramas will go up, and the value of such dramas will rise. Prominent dramas will be the focal point that all platforms compete for.

The report consists of the following aspects:

- Overview of China TV drama Industry (including industrial chain, business models, profit models, relevant policies, television channels, TV advertising industry, online video industry, etc.)
- Chinese TV drama market (including status quo, supply and demand, revenue, export, prospect, etc.)
- Chinese TV drama production, distribution and broadcast markets (including status quo, competitive patterns, comparison between listed companies, TV stations, network broadcasting, etc.)
- The market of introduced TV dramas by China (including policies, status quo, competitive patterns, etc.)
- Operating performance, revenue structure, gross margin, TV drama business, competitive advantages, development strategies and prospect of major Chinese TV drama producers (including Huace, Huayi Brothers, HaiRun, etc.)

To view the table of contents and know more details please visit  China TV Drama Industry Report,2013-2016.

European Offshore Wind Industry, 2013 - H2 Installations Set to Outpace H1

Reportstack has announced a new market report on European Offshore Wind Industry, 2013 - H2 Installations Set to Outpace H1. The offshore wind industry is growing rapidly in European countries, and more than 90% of global installed offshore wind capacity is located in European waters. In 2012, Europe’s offshore wind capacity amounted to almost 5 Gigawatts (GW), and a further 1 GW of capacity was added by the first half (H1) of 2013. The number of offshore grid connections in H1 2013 increased by 100% compared to offshore grid connections in H1 2012. This success is expected to continue for installations in the second half (H2) of 2013. The projects currently under construction are expected to represent the addition of more than 1 GW of active capacity by the end of 2013. The heavy addition of capacity in the offshore wind sector is fueled by government support and an increase in the number of players in the industry such as developers, owners, turbine manufacturers, foundation manufacturers, vessel providers, and installation facilitators. These contributors are expanding their expertise in order to increase the commercially operating capacity, achieve the goals set by individual countries in Europe, and be a part of the region’s offshore industry.

Scope

- The report provides updates on growth trend in European offshore wind installations for year 2013.
- It majorly details second half year expected installations in comparison to first half installations.

Reasons to buy

- The report provides outlook on European offshore wind industry for 2013.
- It also details the future growth of these markets in the H2, 2013.

To view the table of contents and know more details please visit European Offshore Wind Industry, 2013 - H2 Installations Set to Outpace H1 report.

Hydropower (Large Hydro, Small Hydro and Pumped Storage), 2013 Update

Reportstack has announced a new market report on Hydropower (Large Hydro, Small Hydro and Pumped Storage), 2013 Update - Global Market Size, Competitive Landscape, Regulations and Investment Analysis to 2020” is the latest report, the industry analysis specialists that offer comprehensive information and understanding of the market trends of the alternative energy industry. The report provides an understanding of the global hydropower market including the market analysis of the key countries – the US, Canada, Brazil, Russian Federation, Norway, China, Japan and India. It details historic (2006–2012) and forecast data (2013–2020) for installed capacity and power generation split by large-hydro, small-hydro and pumped storage. It also covers deal analysis, investment analysis, competitive landscape of hydropower project owners and major policies impacting the hydropower market in each of the covered countries. Additionally, the report also covers the three emerging hydropower countries – Mexico, Turkey and Vietnam. Emerging countries chapter details installed capacity and power generation split by large-hydro, small-hydro and pumped storage, deal analysis and major policies impacting the hydropower market of the countries. The report is built using information available from primary and secondary research, and in-house analysis by team of industry experts.

Scope

The report analyses global hydropower market. Its scope includes -
- The report gives an introduction of the global hydropower market. Major countries included in the report – the US, Canada, Brazil, Russian Federation, Norway, China, Japan and India. In addition, introduction of the three emerging hydropower countries – Mexico, Turkey and Vietnam.
- Historic and forecast statistics for hydropower installed capacity and power generation from 2006 to 2020 globally and for the covered countries.
- The report provides the deal analysis, investment analysis, competitive landscape of hydropower project owners and major policies impacting the hydropower market in each of the key countries – US, Canada, Brazil, Russian Federation, Norway, China, Japan and India.
- The report also provides the deal analysis and major policies impacting the hydropower market for the emerging countries – Mexico, Turkey and Vietnam.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Facilitate decision making based on historic and forecast data for hydropower installed capacity and power generation.
- Develop strategies based on the latest market trends and deals information in the hydropower market.
- Position yourself to gain the maximum advantage of the industry’s growth potential by developing strategies based on the latest operational and regulatory events.
- Identify key hydropower market and business development avenues.
- Respond to your competitors’ business structure, strategy and prospects.

To view the table of contents and know more details please visit  Hydropower (Large Hydro, Small Hydro and Pumped Storage), 2013 Update report.

AB SKF to Acquire US-based Kaydon Corporation

Reportstack has announced a new market report on AB SKF to Acquire US-based Kaydon Corporation. AB SKF (SKF), a Swedish bearing company, has announced the acquisition of Kaydon Corporation (Kaydon), a US-based designer and manufacturer of performance-critical and engineered products. The total value of the acquisition is approximately $1.25 billion, which includes $95m of net debt. The share price of the acquisition amounts to $35.50, to be paid in cash. The transaction will be financed by SKF’s existing cash and credit lines and will be accretive to its earnings per share in coming years. SKF will buy all of Kaydon’s outstanding shares by issuing an all-cash tender offer. With this attainment, SKF will become the leading manufacturer and supplier of bearings and velocity control products in North America.

Scope

- The deal report analysis the key drivers of this deal.
- The report covers the brief overview of the companies involved in the transaction and few comparable deals.

Reasons to buy

- This report provides insight about the deal, deal drivers, and the role of companies involved in the deal.

To view the table of contents and know more details please visit AB SKF to Acquire US-based Kaydon Corporation report.

H1 2013 Global Solar Market Outlook

Reportstack has announced a new market report on H1 2013 Global Solar Market Outlook. Global solar Photovoltaic (PV) installations has started showing positive growth in Q2 2013 as shipments increased with shift of focus from Europe to Asia-Pacific with China and Japan set to be the new market leaders for Solar PV in 2013.The Concentrated Solar Power (CSP) has set foot in new markets in India and United Arab Emirates(UAE).

Scope

- The report provide insight on the solar power development in H1 2013, give the commentary on the development during 2012-2017 in key countries and other trends.

Reasons to buy

- The report provide insight on the solar power development in H1 2013.
- It covers the solar PV and solar CSP market for 2012 - 2015 in the key countries.
- It provide demand-supply outlook for the solar PV and solar CSP.
- It also comments about the solar modules price trends and global levelized cost of energy.

To view the table of contents and know more details please visit  H1 2013 Global Solar Market Outlook report.

Gauss Energia S.A. Secures Final $75m of Project Financing for Aura Solar I in Mexico

Reportstack has announced a new market report on Gauss Energia S.A. Secures Final $75m of Project Financing for Aura Solar I in Mexico. Gauss Energia S.A. (Gauss Energia) has completed the project financing for the construction and development of Aura Solar I, a 30 Megawatt (MW) Photovoltaic (PV) plant in La Paz, Mexico. Nacional Financiera S.N.C. (Nafinsa) and the International Finance Corporation (IFC) provided the final $75m of the total $100m raised.

Scope

- The deal report analysis the key drivers of this deal.
- The report covers the brief overview of the companies involved in the transaction and few comparable deals.

Reasons to buy

- This report provides insight about the deal, deal drivers, role of local players amdNacional Financiera S.N.C. (Nafinsa) and the International Finance Corporation in the deal.

To view the table of contents and know more details please visit Gauss Energia S.A. Secures Final $75m of Project Financing for Aura Solar I in Mexico report.

MediPoint: Hernia Repair - Current and Future Players

Reportstack has announced a new market report on MediPoint: Hernia Repair - Current and Future Players. Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation biologic and composite meshes in developed countries and adoption of laparoscopic techniques worldwide, will drive hernia repair market growth in the US, Europe and Asia Pacific. Saturated with numerous players and a library of different products, the fiercely-competitive hernia mesh industry has experienced notable improvements recently in device quality and affordability, as companies strive for increased physician adoption in established markets and strategize entry into new regions.

The report identifies and analyzes the key companies shaping and driving the global hernia repair market. The report provides insight into the competitive hernia repair landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading surgeons, with in-house analysis conducted by a team of industry experts.

Scope

- Investigation of current and future market competition for hernia repair
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as surgeons using hernia repair devices in clinical practice.

Reasons to buy

- Gain a high level view of the trends shaping and driving the hernia repair market for coronary applications and peripheral applications in the lower extremity.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

The Companies Mentioned in this report are Abiss Analytic Biosurgical Solutions AMI: Agency for Medical Innovation Angiologica Aspide Medical Assut Europe Atrium Medical B. Braun Surgical Cook Medical Cousin Biotech Covidien C.R. Bard Ethicon FEG Textiltechnik mbH Proxy Biomedical TEI Biosciences W. L. Gore & Associates

To view the table of contents and know more details please visit MediPoint: Hernia Repair - Current and Future Players report. 

Similar Reports:

MediPoint: Trauma Fixation - Current and Future Players

Smart Grid Review - October 2013

Reportstack has announced a new market report on Smart Grid Review - October 2013 which provides update on the global developments related to smart grid deployment across the globe during the month of September 2013.

Scope

- Market prospect for companies providing smart grid systems
- Key product launch in power grids
- Major news and deals in smart grid
- Upcoming smart grid events

Reasons to buy

- Identify key growth and investment opportunities in smart grid sector
- Gain insight on the industry’s growth potential
- Developing strategies for market penetration
- Facilitate decision-making based on information on key developments in smart grids.

To view the table of contents and know more details please visit  Smart Grid Review - October 2013 report

Wind Power in India, Market Outlook to 2025, 2013 Update

Reportstack has announced a new market report on Wind Power in India, Market Outlook to 2025, 2013 Update - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report, the industry analysis specialists that offer comprehensive information and understanding of the wind power market in India. The report provides in depth analysis on global renewable power market and global wind power market with forecasts up to 2025. The report analyzes the power market scenario in India (includes thermal conventional, nuclear, large hydro and renewables) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, small hydro, biopower and solar PV) and provides forecasts up to 2025. The report highlights installed capacity and power generation trends from 2001 to 2025 in India wind power market. The research analyzes market segmentation by onshore and offshore wind, installed capacity split by state, investment trends, LCOE for wind power in India during 2012-2025, owners and developers share in 2012, projects based analysis, turbine market share and market size, average turbine size and import export of wind turbines. The report provides information on the amount of carbon saved (in million tons) and average number of homes powered by wind power until 2025. A detailed coverage of renewable energy policy framework governing the market with specific policies pertaining to wind power development in India is provided in the report. The research also provides company snapshots of some of the major market participants.

Scope

The report analyses global renewable power market, global wind power market, India power market, India renewable power market and India wind power market. The scope of the research includes -
- A brief introduction on global carbon emissions and global primary energy consumption.
- Historical period is during 2001-2012 (unless specified) and forecast period is for 2013-2025.
- An overview on global renewable power market, highlighting installed capacity trends, generation trends and installed capacity split by various renewable power sources.
- Renewable power sources include wind (includes both onshore and offshore), solar photovoltaic (PV), concentrated solar power (CSP), small hydropower (SHP), biomass, biogas and geothermal.
- Detailed overview on the global wind power market with installed capacity and generation trends, market segmentation by onshore and offshore wind, installed capacity split by region, installed capacity split by major wind power countries in 2012, market share of wind equipment manufacturers (wind turbine, gearbox, rotor blades, generators), investment trends (2013-2025), global wind turbine trade flow (2001-2012) and detailed cost analysis which includes LCOE comparison among major countries.
- Power market scenario in India and provides detailed market overview, installed capacity and power generation trends by various fuel types (includes thermal conventional, nuclear, large hydro and renewables) with forecasts up to 2025.
- An overview on India renewable power market, highlighting installed capacity trends (2001-2025), generation trends(2001-2025), installed capacity split by various renewable power sources in 2012 and LCOE comparison among various technologies.
- Detailed overview of India wind power market with installed capacity and generation trends, market segmentation by onshore and offshore wind, installed capacity split by state, market share of wind turbine manufacturers in 2012, investment trends (2013-2025), imports-exports of wind turbines (2001-2012), carbon savings), number of homes powered and LCOE for wind during 2012-2025.
- Deal analysis of India wind power market. Deals are analyzed on the basis of mergers, acquisitions, partnership, asset finance, debt offering, equity offering, private equity (PE) and venture capitalists (VC).
- Key policies and regulatory framework supporting the development of renewable power sources in the country in general and wind in particular.
- Company snapshots of some of the major market participants.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to -
- Identify key growth and investment opportunities in India wind power market.
- Facilitate decision-making based on strong historic and forecast data for nuclear power market.
- Position yourself to gain the maximum advantage of the industry’s growth potential.
- Develop strategies based on the latest regulatory events.
- Identify key partners and business development avenues.
- Understand and respond to your competitors’ business structure, strategy and prospects.

The Companies Mentioned in this report are Vestas Wind Systems A/S Enercon GmbH Suzlon Energy Limited Gamesa Corporacion Technologica.

To view the table of contents and know more details please visit Wind Power in India, Market Outlook to 2025, 2013 Update report. 

Similar Reports:

Wind Power in Canada, Market Outlook to 2025, 2013 Update

Wind Power in Brazil, Market Outlook to 2025, 2013 Update 

Thermal Power in Turkey, Market Outlook to 2025, 2013 Update

Reportstack has announced a new market report on Thermal Power in Turkey, Market Outlook to 2025, 2013 Update- - Capacity, Generation, Power Plants, Regulations and Company Profiles” is the latest report,  the industry analysis specialists that offer comprehensive information and understanding of the thermal power market in Turkey. The report provides in depth analysis on global thermal power market with forecasts up to 2025. The report analyzes the power market scenario in Turkey (includes thermal conventional, nuclear, large hydro, pumped storage and renewables) and provides future outlook with forecasts up to 2025. The research details thermal power market outlook in the country and provides forecasts up to 2025. The report highlights installed capacity and power generation trends from 2001 to 2025 in Turkey thermal power market. A detailed coverage of thermal energy policy framework governing the market with specific policies pertaining to thermal is provided in the report. The research also provides details of active thermal power plants in the country, upcoming thermal installation details and company snapshots of some of the major market participants.

Scope

The report analyses global thermal power market, Turkey power market and Turkey thermal power market. The scope of the research includes -
- A brief introduction on global carbon emissions and global primary energy consumption.
- Historical period is during 2001-2012 (unless specified) and forecast period is for 2013-2025.
- Detailed overview on the global thermal power market with installed capacity and generation trends, market forces analysis (drivers, restraints and challenges), installed capacity by fuel type, installed capacity split by region, installed capacity split by major countries and cross country comparison among thermal sources such as coal, oil and gas.
- Power market scenario in Turkey and provides detailed market overview, installed capacity and power generation trends by various fuel types (includes thermal conventional, nuclear, large hydro and renewables) with forecasts up to 2025.
- Detailed overview of Turkey thermal power market with installed capacity and generation trends, installed capacity by fuel type, net capacity addition by fuel type, owners share, market size of major equipments such as steam generator and turbine, and information on major active and upcoming projects.
- Key policies and regulatory framework supporting thermal power development.
- Company snapshots of some of the major market participants in the country.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to -
- Identify key growth and investment opportunities in Turkey thermal power market.
- Facilitate decision-making based on strong historic and forecast data for thermal power market.
- Position yourself to gain the maximum advantage of the industry’s growth potential.
- Develop strategies based on the latest regulatory events.
- Identify key partners and business development avenues.
- Understand and respond to your competitors’ business structure, strategy and prospects.

The Companies Mentioned in this report are Aksa Enerji Uretim A.S. Electricity Generation Company Enerjisa Enerji Uretim A.S. Iskenderun Enerji Uretim Ve Ticaret A.S.

To view the table of contents and know more details please visit  Thermal Power in Turkey, Market Outlook to 2025, 2013 Update  report. 

Similar Reports:

Thermal Power in Russia, Market Outlook to 2025, 2013 Update

Thermal Power in Germany, Market Outlook to 2025, 2013 Update

MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts

Reportstack has announced a new market report on MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts which is an essential source of information and analysis on the drug-eluting balloons (DEB) market in the US. The report provides in-depth insight into the use of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occlusions, acute myocardial infarction and lesions in diabetics.

The DEB market in the US was assessed to identify the unmet needs in the market, understand the regulatory challenges DEB manufacturers will encounter in the US, identify the challenges to adoption in clinical practice and evaluate future adoption of DEB for select coronary and peripheral indications. The US sales expectations are discussed through careful analysis of adoption patterns of using DEB. Clients can use this report to better understand the scope of this technology and for strategic planning to explore opportunities in this dynamic market. The report provides insights into the competitive landscape, the marketed and pipeline DEB products, the current and emerging players and comparative market analysis of different types of interventional techniques used to treat coronary and peripheral artery disease. This report is built using data and information sourced from secondary sources and primary research interviews and survey with leading Interventional Cardiologists and Interventional Radiologists, with in-house analysis conducted by team of industry experts.

Scope

- An overview of coronary artery disease and peripheral artery disease in the lower extremity, which includes epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
- Annualized total drug-eluting balloon market revenue by type of disease, annual cost of disease and drug-eluting balloons adoption pattern and procedure data in the US from 2010-2012 and forecast for seven years to 2019.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access and implications of the drug-eluting balloon market.
- Pipeline analysis: comprehensive data split across different stages of development, emerging trends and DEB designs in development, including investigation of DEB coating technology, antiproliferative agent used, balloon and catheter design and durability.
- Analysis of the current and future market competition in the US drug-eluting balloon market. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends that will shape and drive the DEB market in the US.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the US DEB market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the US DEB market by disease and indication from 2010-2019.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

The Companies Mentioned in this report are Aachen Resonance AnGes MG AngioScore AVIDAL Vascular B. Braun Biosensors International Biotronik Blue Medical Boston Scientific Corporation Caliber Therapeutics Cardionovum Concept Medical Research Cook Medical Covidien C.R. Bard DSM Biomedical Elixir Medical Corporation Eurocor LifeTech Scientific Corporation Medtronic Micell Technologies Minvasys TriReme Medical Vascular Nanotransfer Technologies.

To view the table of contents and know more details please visit MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts report. 

Similar Reports:

MediPoint: Drug-Eluting Balloons - South American Analysis and Market Forecasts

MediPoint: Drug-Eluting Balloons - APAC Analysis and Market Forecasts

MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts

The Commercial Helicopter Market 2013-2023

Reportstack has announced a new market report on The Commercial Helicopter Market 2013-2023 which is the result of extensive market and company research covering the global Commercial Helicopter industry. It provides detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of the leading companies in the industry, and key news. “The Global Commercial Helicopter Market 2013–2023” offers the reader detailed analysis of the global Commercial Helicopter market over the next ten years, alongside potential market opportunities to enter the industry, using detailed market size forecasts.

The global commercial helicopter sector is expected to experience a growth of 3.08% growth during the forecast period. The commercial helicopter market grows on the back of several sectors worldwide including offshore oil and gas exploration and production, HEMS, VIP transport, law enforcement and public safety etc. Europe and North America which are largest markets for civil helicopters are however saturated markets and thus are not expected to register considerable growth in their market size during the forecast period. Besides, the European market is also expected to experience a marginal decline owing to increased procurement in the first few years of the forecast period and a resultant lowered demand during the second half of the forecast period. Emerging markets of Asia Pacific, Latin America and Middle East are expected to provide the necessary boost to the industry during the forecast period.

“The Global Commercial Helicopter Market 2013–2023” provides detailed analysis of the current industry size and growth expectations from 2013 to 2023, including highlights of key growth stimulators. It also benchmarks the industry against key global markets and provides detailed understanding of emerging opportunities in specific areas.

Key Features and Benefits
The report provides detailed analysis of the market for Commercial Helicopter during 2013–2023, including the factors that influence why countries are investing or cutting helicopter expenditure. It provides detailed expectations of growth rates and projected total expenditure.

29% of the civil helicopters across the world are used for emergency medical services and law enforcement; however this segment is almost negligible in the context of China, India and Middle Eastern countries. Therefore, manufacturers like Bell Helicopter, Eurocopter, MD Helicopters and others are vying to attain a share in the EMS helicopters sector in these untapped markets. Eurocopter projects a requirement of approximately 50 helicopters for medical emergency services in India during the next few years. The government should formulate policies to waive off or charge minimal on jet fuel taxes, landing charges so as to make HEMS affordable during the forecast period.

Key Market Issues
With the fast-growing market for civil helicopters across the world, it is even difficult to fulfill the requirement of trained commercial pilots and technicians for service and support function. Market like China, which is expected to add additional 2000 and more helicopter during the forecast period, would at least require 6300 helicopter pilots. On one side, manufacturers like Bell helicopters is viewing China as a strong potential market in the Asia-Pacific region and are trying to increase the sales and simultaneously helping to overcome the challenge of lack of pilots by signing agreements with aviation colleges. Bell signed a memorandum of agreement with Guangzhou Civil Aviation College for helicopter-maintenance training facility in China which is anticipated to be operational by the end of 2013.Training by Bell is specific to the variants including Bell 206 and 407. Similarly the Indian market is witnessing the expanding scope of operation in civil aviation but is facing the challenge of lack of pilots and training facilities in the country.

Reforms are needed in the low-altitude airspace which is a major challenge in growing markets like China and India in order to boost the growing demand in the helicopter industry. Chinese civil aviation authority is streamlining the process and plans to expand the flying air space for civil helicopters by 2015. The reason the authorities are delaying the process is due to the threat that foreign air-carriers would monopolize the market with their established products. Additionally in India the lack of helipads and landing infrastructure will hinder the growth of helicopters. The infrastructure is non-existent in both urban and the remote areas creating worst times for the country during a disaster or emergency situation. The Rotary Wing Society of India (RWSI) is putting efforts in developing an authenticated registered directory of the operating and available helipads, which is currently lacking in the country. Limited airport airspace is another obstacle, where helicopter operations are majorly flying in Delhi and Mumbai, due to latter proximity to the sea-based oil rigs, airports are over-crowded with heavy air traffic due to fixed-wing operations which is resulting in lower slots and priority to the helicopter operators.

Key Highlights
North America and Europe have been the most important and prominent markets for commercial helicopter manufacturers until the last few years. However, the scenario has changed significantly in the recent years due to the saturation of the aforementioned markets due to which the growth was almost stagnant. Asia Pacific and Middle East are expected to be the growth centers for commercial helicopters during the forecast period owing to the huge potential in countries such as China, India, Australia, Japan, UAE, Qatar, etc. Additionally, the steadily growing oil and gas industry of the Middle Eastern countries is creating substantial demand for commercial helicopters to meet its increasing need for offshore transport in the coming years. EMS is also expected to be a considerable factor driving the market for civil helicopters in the Asia Pacific and Middle East during the forecast period, as countries in these regions still do not have an established EMS network compared to country in North America and Europe. Latin America is another region that is expected to witness robust demand for commercial helicopters registering a CAGR of 14.99% during the forecast period. This rapid growth in the region can be attributed to the strong economic growth in the countries such as Brazil and Mexico.

Even though light helicopters account for the smallest spending in the global commercial helicopter market during the forecast period, the segment is expected to grow robustly. This can be attributed to the rapidly increasing business from VIP or corporate transport and EMS firms and also the parapublic departments. In the present economic scenario, light helicopters are increasingly seen as a favorable choice by various organizations owing to their low price and latest technological advancements in the avionics and navigation systems. The global fleet of light helicopters as a percentage of larger helicopters fleet is thus increasing at a fast rate.

The Companies Mentioned in this report are AgustaWestland, Bell Helicopter, Eurocopter, Russian Helicopters, MD Helicopters, Robinson Helicopter Company, Aviation Industry Corporation of China

To view the table of contents and know more details please visit The Commercial Helicopter Market 2013-2023 report.

MediPoint: Trauma Fixation - US Analysis and Market Forecasts

Reportstack has announced a new market report on MediPoint: Trauma Fixation - US Analysis and Market Forecasts. Traumatic injury patients that come into the Emergency Room (ER) experience orthopedic injury in the form of fractures 60% to 65% of the time, based on conversations with key opinion leaders. Of this population, 45%–50% are operable and require fracture repair techniques in the form of external or internal fixation. As the global population continues to grow in the emerging markets, with overcrowding and economic growth, some of the drivers for trauma fixation include motor vehicle accidents and aging. The analysis shows that while the orthopedics implant market is mature, where products have become commodities, trauma fixation is one that has room for more technological development and adoption.

There are multiple drivers that contribute to the current state of the trauma fixation market. While factors such as reimbursement are currently not a challenge in the US for procedures and implants based on the proper indications, lowering physician reimbursement has driven orthopedic surgeons to seek other revenue streams and hold back some of the procedural numbers in joint replacement, stunting growth. This has in turn created more positive growth in plating and nail technology.

Scope

- An overview of bone trauma, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized US trauma fixation market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for trauma fixation
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the trauma fixation sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as Orthopedic Surgeons.

Reasons to buy

- Understand the trends shaping and driving the US trauma fixation Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the US trauma fixation market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in US trauma fixation market landscape? Identify, understand and capitalize.

The Companies Mentioned in this report are Acumed Biomet DePuy Synthes International Integra LifeSciences Orthofix OsteoMed Small Bone Innovations, Inc. Smith & Nephew Stryker Tornier Trimed Inc. Wright Medical Zimmer.

To view the table of contents and know more details please visit MediPoint: Trauma Fixation - US Analysis and Market Forecasts report.

Similar Reports:

MediPoint: Trauma Fixation - South American Analysis and Market Forecasts 

MediPoint: Trauma Fixation - EU Analysis and Market Forecasts

MediPoint: Trauma Fixation - APAC Analysis and Market Forecasts.

PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022

Reportstack has announced a new market report on PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022. Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines. Currently, tetravalent conjugate vaccines, such as Sanofi’s Menactra and Novartis’ Menveo, account for the vast majority of global sales, with the US adolescent market being the key target segment. GlobalData expects growth in the meningococcal vaccines market to be primarily driven by the launch of serotype B vaccines, which address a critical unmet need in the treatment landscape. Vaccines that better protect infants and/or provide a longer duration of immunity also have an opportunity to seize market share during 2012-2022.

These vaccines, which include a MenC conjugate vaccine and a heptavalent pediatric vaccine (DTP-Hib-HepB-IPV-MenC) are being developed and produced by government-sponsored institutions such as Bio-Manguinhos, Instituto Butantan, Fiocruz, and FUNED. Once they become widely available, these vaccines will quickly steal market share from private manufacturers because of their cost-effectiveness advantage.

Scope

- Overview of Meningococcal Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in Brazil including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in Brazil from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting Brazil Meningococcal Vaccines market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Meningococcal Vaccines
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of drug performance
- Obtain sales forecast for drugs from 2012-2022 in Brazil

To view the table of contents and know more details please visit PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022 report. 

Similar Reports:

PharmaPoint: Meningococcal Vaccines - Australia Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Italy Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - France Drug Forecast and Market Analysis to 2022

Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Reportstack has announced a new market report on Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022. Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines.

Menitorix (Meningococcal Groups C and Haemophilus b Tetanus Toxoid Conjugate Vaccine) is the brand name for GSK’s Hib-MenC conjugate vaccine sold in the UK and Spain. Approved in 2012, Menitorix was the first meningococcal conjugate vaccine to also provide protection against Hib.

Scope

- Overview of Meningococcal disease, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Menitorix including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Menitorix for the top nine countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, Australia and Brazil.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for meningococcal vaccines
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of Menitorix performance
- Obtain sales forecast for Menitorix from 2012-2022 in top nine countries (the US, France, Germany, Italy, Spain, the UK, Japan, Brazil and China).

To view the table of contents and know more details please visit Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 report. 

Similar Reports:

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menactra (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

MnB rLP2086 (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Reportstack has announced a new market report on MnB rLP2086 (Meningococcal Vaccines) - Forecast and Market Analysis to 2022. Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines.

MnB rLP2086 is Pfizer’s recombinant protein vaccine that protects against MenB disease. Despite Pfizer’s position as a major player in the vaccine industry, MnB rLP2086 is currently the only meningococcal vaccine in the pharmaceutical giant’s portfolio. Originally developed by Wyeth, Pfizer acquired MnB rLP2086 with its purchase of the company in 2009. MnB rLP2086 is a bivalent vaccine composed of two variants of the N. meningitidis OMP LP2086, A05, and B01. LP086 is a lipoprotein (LP) linked to the outer membrane of the bacteria and promotes in vivo survival by binding Factor H and facilitating complement evasion.

Scope

- Overview of Meningococcal disease, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on MnB rLP2086 including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for MnB rLP2086 for the top nine countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, Australia and Brazil.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for meningococcal vaccines
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of MnB rLP2086 performance
- Obtain sales forecast for MnB rLP2086 from 2012-2022 in top nine countries (the US, France, Germany, Italy, Spain, the UK, Japan, Brazil and China)

To view the table of contents and know more details please visit MnB rLP2086 (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 report. 

Similar Reports:

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menomune (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022